Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the LUMIR challenge: The pathway to foundational registration models.

Medical image analysis·2026
Same author

Free-Breathing Dynamic, Regularized, Adaptive Cluster Optimization (DRACO) Cine Cardiac MRI in Atrial Fibrillation.

Journal of magnetic resonance imaging : JMRI·2026
Same author

Survey of work-from-home experiences among medical physicists in Southern California during and after the COVID-19 pandemic.

Journal of applied clinical medical physics·2026
Same author

Hierarchical heated markov modeling for synthesizing activity data from wearable devices.

Computational and structural biotechnology journal·2026
Same author

Benchmark of Segmentation Techniques for Pelvic Fracture in CT and X-Ray: Summary of the PENGWIN 2024 Challenge.

IEEE transactions on medical imaging·2026
Same author

CIP2A mediates mitotic recruitment of SLX4/MUS81/XPF to resolve replication stress-induced DNA lesions.

Nature communications·2025
Same journal

Correction to "On the shape of the radiation survival curve in tumor spheroids: The role of oxygen heterogeneity".

Medical physics·2026
Same journal

Multi-view constrained semi-supervised vertebra detection for 3D ultrasound spine volume.

Medical physics·2026
Same journal

Accuracy of quantitative <sup>177</sup>Lu SPECT/CT imaging: A systematic review.

Medical physics·2026
Same journal

Physics-constrained dual-domain network for CBCT reconstruction from orthogonal X-rays in gynecologic radiotherapy.

Medical physics·2026
Same journal

Decomposition-based harmonization for quantitative PET imaging across scanners and radiotracers.

Medical physics·2026
Same journal

Development and evaluation of an in vivo dose-based monitoring system for electron FLASH radiation therapy.

Medical physics·2026
See all related articles

Related Experiment Video

Updated: May 10, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Dose-shaping using targeted sparse optimization.

George A Sayre1, Dan Ruan

  • 1Department of Radiation Oncology, University of California - Los Angeles School of Medicine, 200 Medical Plaza, Los Angeles, California 90095, USA.

Medical Physics
|July 5, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces a novel objective function for radiation therapy planning, improving tradeoff between target coverage, organ-sparing, and PTV homogeneity. The method enhances dose-shaping and OAR-sparing for complex cases, leading to better plan quality and deliverability.

More Related Videos

A Simple Stimulatory Device for Evoking Point-like Tactile Stimuli: A Searchlight for LFP to Spike Transitions
07:34

A Simple Stimulatory Device for Evoking Point-like Tactile Stimuli: A Searchlight for LFP to Spike Transitions

Published on: March 25, 2014

Related Experiment Videos

Last Updated: May 10, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Simple Stimulatory Device for Evoking Point-like Tactile Stimuli: A Searchlight for LFP to Spike Transitions
07:34

A Simple Stimulatory Device for Evoking Point-like Tactile Stimuli: A Searchlight for LFP to Spike Transitions

Published on: March 25, 2014

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Computational Biology

Background:

  • Dose volume histograms (DVHs) are standard for radiation therapy plan quality assessment.
  • DVHs lack spatial information, necessitating manual review of dose maps for phenomena like hot spots.
  • Controlling spatial dose distribution, crucial for clinical outcomes, has been underexplored.

Purpose of the Study:

  • To introduce a novel objective function for radiation therapy planning.
  • To enable direct tradeoff between target coverage, organ-at-risk (OAR) sparing, and planning target volume (PTV) homogeneity.
  • To illustrate the method's advantages and applicability in various cancer cases.

Main Methods:

  • Developed an energy minimization objective function (E tot (sparse)) using robust cost functions.
  • Incorporated an asymmetric linear well for PTV dose penalties and a two-piece linear function for OAR dose penalties.
  • Utilized total variation energy (L1 norm of dose gradient) for PTV homogeneity and compared with conventional quadratic objectives.

Main Results:

  • The E tot (sparse) method demonstrated flexibility in balancing OAR sparing and PTV homogeneity.
  • Plans optimized with E tot (sparse) showed improved PTV homogeneity and OAR sparing (e.g., spinal cord, parotid glands) in pancreas and head-and-neck cases.
  • E tot (sparse)-optimized plans exhibited superior deliverability compared to clinical plans, assessed by the 2D modulation index.

Conclusions:

  • The proposed formulation enhances dose-shaping and OAR sparing, particularly for complex sites like the pancreas and head and neck.
  • The linear programming nature of the objective function ensures fast convergence to the global minimum and ease of clinical implementation.
  • This method is expected to positively impact radiation therapy plan quality for challenging disease sites.